Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca 2+ Signaling
Oral Diseases · 2026-10 · 32 (10) · 3197-3206
DOI: 10.1111/odi.70410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 27.07.2026. Verfasst von Chaelin Chung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Xerostomia, Antipsychotic Agents, Calcium Signaling, Salivary Glands. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Objectives
Antipsychotic‐induced salivary dysfunction such as hyposalivation is a prevalent clinical challenge that severely compromises oral health and quality of life. Although typical and atypical antipsychotics have their therapeutic target in the central nervous system, their direct molecular mechanisms within the salivary glands remain poorly understood. Here we investigated the molecular mechanism underlying hyposalivation induced by antipsychotics: olanzapine, haloperidol, and risperidone.
Methods
We reanalyzed scRNA‐seq data from salivary gland cells, measured the intracellular Ca 2+ ([Ca 2+ ] i ) in the human salivary gland NS‐SV‐AC cells, and salivary secretion in the mouse model.
Results
We found a complete absence of dopamine D2 and serotonin 5‐HT2A receptor expression in both human and mouse salivary gland cells. Functional assays demonstrated that olanzapine and haloperidol inhibited muscarinic receptor‐mediated [Ca 2+ ] i increases, whereas risperidone did not. Notably, these agents did not suppress store‐operated calcium entry (SOCE) or purinergic receptor‐mediated signaling. Olanzapine shows inhibition of the pilocarpine‐induced salivary secretion in a mouse model.
Conclusions
Our findings indicate that antipsychotic‐induced hyposalivation can be driven by the direct peripheral inhibition of muscarinic receptors within the salivary glands, rather than through dopaminergic or serotonergic antagonism, and support the mechanism‐based preventive protocols for patients on long‐term antipsychotic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, Republic of Korea.
- Department of Oral Medicine and Oral Diagnosis, Dental Research Institute, Seoul National University School of Dentistry, Seoul, Republic of Korea.
- Department of Oral Medicine, National University Dental Hospital, Seoul, Republic of Korea.
ORCID-Profile: Se-Young Choi
Förderung
- National Research Foundation of Korea
Zitieren
APA
Chung, C., Kim, S., Kim, Y. B., Park, H. K., & Choi, S. Y. (2026). Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca 2+ Signaling. Oral Diseases, 32(10), 3197-3206. https://doi.org/10.1111/odi.70410
Vancouver
Chung C, Kim S, Kim YB, Park HK, Choi SY. Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca 2+ Signaling. Oral Diseases. 2026;32(10):3197-3206. doi:10.1111/odi.70410
BibTeX
@article{Chung2026,
author = {Chung, Chaelin and Kim, Soohyun and Kim, Yoo-Bin and Park, Hee-Kyung and Choi, Se-Young},
title = {Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca 2+ Signaling},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {10},
pages = {3197--3206},
doi = {10.1111/odi.70410}
}
EUVIMED